<!DOCTYPE html>
<html lang="en">
<head>
  <!-- Google tag (gtag.js) -->
  <script async src="https://www.googletagmanager.com/gtag/js?id=G-LSRR4KW715"></script>
  <script>
    window.dataLayer = window.dataLayer || [];
    function gtag(){dataLayer.push(arguments);}
    gtag('js', new Date());

    gtag('config', 'G-LSRR4KW715');
  </script>


  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>Case 8.7 - Anal Fissures, Cancers and STIs [SDL]</title>

  <!-- Favicon -->
  <link rel="icon" type="image/png" href="../assets/ShepTech logo.png">
  <link rel="apple-touch-icon" href="../assets/ShepTech logo.png">

  <!-- Primary Meta Tags -->
  <meta name="title" content="Case 8.7 - Anal Fissures, Cancers and STIs [SDL] | MD3 SCP Cases">
  <meta name="description" content="Medical case study for MD3 students.">

  <!-- Open Graph / Facebook -->
  <meta property="fb:app_id" content="your_facebook_app_id">
  <meta property="og:type" content="article">
  <meta property="og:title" content="Case 8.7 - Anal Fissures, Cancers and STIs [SDL]">
  <meta property="og:site_name" content="MD3 SCP Cases">
  <meta property="og:description" content="Medical case study for MD3 students.">
  <meta property="og:image" content="https://md3-scp.netlify.app/assets/ShepTech%20logo.png">
  <link rel="stylesheet" href="../css/case.css">

  <!-- Firebase SDK -->
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-app-compat.js"></script>
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-auth-compat.js"></script>
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-firestore-compat.js"></script>
</head>
<body>
  <div class="container">
    <div class="case-header">
      <a href="#" class="back-link" onclick="goBack(event)">← Back to Cases</a>
    </div>

    <h1>Case 8.7 – Anal Fissures, Cancers and STIs [SDL]</h1>
    <p class="meta"><strong>Category:</strong> Surgery | <strong>Discipline:</strong> Surgery - GIT | <strong>Setting:</strong> General Practice</p>

    <h2>Case</h2>
    <p>Marian Fisher, aged 25 years, presents complaining of severe anal pain. It started following an episode of constipation a week ago and has not improved. She can't open her bowels now as it is too painful. The pain is sharp and severe.</p>

    <h2>Questions</h2>

    <div class="question">
      <strong>1. What further history and examination would you undertake?</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <p><strong>Further History and Examination:</strong></p>
        <ul>
          <li><strong>Complete GIT history</strong> - bowel habits, dietary factors, previous episodes, family history</li>
          <li><strong>Thorough GIT examination</strong> - abdominal examination</li>
          <li><strong>Visual and digital rectal examination</strong> - inspect for fissures, tags, hemorrhoids; assess sphincter tone</li>
          <li><strong>Proctoscopy</strong> - if tolerated, to visualize anal canal and lower rectum</li>
        </ul>
      </div>
    </div>

    <div class="question">
      <strong>2. On examination you identify a tender anal fissure. How do anal fissures typically present?</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <p><strong>Clinical Presentation of Anal Fissures:</strong></p>

        <h3>Symptoms</h3>
        <ul>
          <li><strong>Most common cause of severe localized anorectal pain</strong></li>
          <li><strong>Pain dramatically increased during bowel movements</strong></li>
          <li>Pain typically starts with defecation and may persist from minutes to hours, disproportionate to the size of the lesion</li>
          <li><strong>Often associated with streaks of blood in the stool</strong></li>
          <li>Bleeding usually minimal and bright red if present</li>
        </ul>

        <h3>Pathophysiology</h3>
        <ul>
          <li><strong>Anal fissures are painful linear tears in the lining of the anal canal, below the level of the dentate line</strong></li>
          <li><strong>Most often located posteriorly in both sexes</strong>, but women also present with anterior anal fissures</li>
          <li>They occur in the posteroanterior plane because pelvic muscular support is weakest along this axis</li>
          <li><strong>Ectopic lateral fissures suggest an unusual diagnosis</strong> (e.g. Crohn's disease, leukaemia, sexually transmitted disease, malignancy)</li>
          <li>Fissures are secondary to local trauma, either from constipation or excessive diarrhea</li>
        </ul>

        <h3>Examination Findings</h3>
        <ul>
          <li><strong>On examination, gentle retraction of the buttocks will reveal a tear at the anal verge</strong></li>
          <li>Rectal examination is usually associated with severe pain and significant sphincter spasm thus not often well tolerated - consider whether formal per rectal examination will alter management or not</li>
          <li><strong>In cases of chronic recurrent anal fissures, the classic triad is pathognomonic:</strong>
            <ul>
              <li>External skin tag</li>
              <li>A fissure exposing the internal sphincter fibres</li>
              <li>A hypertrophied anal papilla at the level of the dentate line</li>
            </ul>
          </li>
        </ul>
      </div>
    </div>

    <div class="question">
      <strong>3. How are anal fissures treated?</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <p><strong>Treatment of Anal Fissures:</strong></p>
        <p>Treatment is based on the duration and severity of the symptoms.</p>

        <h3>Conservative Management (Acute Fissures)</h3>
        <ul>
          <li><strong>Acute anal fissures usually respond to conservative treatment</strong></li>
          <li><strong>Avoidance of diarrhea or constipation</strong></li>
          <li><strong>Bulk laxatives</strong> to keep bowel movements atraumatic</li>
          <li><strong>Mild non-narcotic analgesic</strong></li>
          <li><strong>Sitz baths</strong> may be helpful</li>
        </ul>

        <h3>Medical Management</h3>
        <ul>
          <li><strong>If not resolving, GTN ointment (Rectogesic) is helpful</strong>
            <ul>
              <li>Reduces muscle spasm</li>
              <li>Aids healing by increased local blood flow</li>
              <li>However, headaches can be a side effect</li>
            </ul>
          </li>
          <li><strong>Botulinum toxin (Botox)</strong> is used in some centres instead of, or before surgery</li>
        </ul>

        <h3>Surgical Management</h3>
        <ul>
          <li><strong>If conservative treatment fails, or the fissure is chronic, surgery is recommended</strong></li>
          <li><strong>In uncomplicated cases, the operative choice is lateral internal sphincterotomy</strong>
            <ul>
              <li>A small portion of the internal sphincter is cut</li>
              <li>Releases the sphincter spasm</li>
              <li>Relieves pain and allows the fissure to heal</li>
              <li>The operation carries a small risk of minor incontinence</li>
              <li><strong>Greater than 95% cure rate</strong></li>
            </ul>
          </li>
        </ul>
      </div>
    </div>

    <div class="question">
      <strong>4. How do anal cancers present in terms of history and examination?</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <p><strong>Anal Cancer Presentation:</strong></p>

        <h3>Epidemiology and Types</h3>
        <ul>
          <li><strong>Perianal and anal canal malignancies are rare</strong>, with less than 1% of the incidence of colorectal cancer</li>
          <li><strong>There are essentially two types of anal cancers:</strong>
            <ul>
              <li><strong>Epidermoid carcinoma</strong> (a generic type that includes squamous cell, basaloid, cloacogenic, mucoepidermoid, and transitional carcinomas)</li>
              <li><strong>Malignant melanoma</strong></li>
            </ul>
          </li>
          <li><strong>The anus is the third most common site for malignant melanoma</strong> (after the skin and eyes)</li>
        </ul>

        <h3>Clinical Presentation</h3>
        <ul>
          <li><strong>Either type of malignancy may cause pain, bleeding, or a lump</strong></li>
          <li><strong>Delay in diagnosis is often a consequence of both patient and physician neglect</strong></li>
        </ul>

        <h3>Malignant Melanoma Specific Features</h3>
        <ul>
          <li><strong>Lymph node involvement and widespread metastases are common at presentation</strong></li>
          <li>Diagnosis often delayed because of lack of pigment in these lesions (amelanotic melanoma)</li>
        </ul>

        <h3>Examination</h3>
        <ul>
          <li><strong>Examination should include palpation of the inguinal lymph nodes</strong></li>
        </ul>

        <h3>Diagnosis</h3>
        <ul>
          <li><strong>Diagnosis depends on incision biopsy</strong> (could be excision biopsy if small less than 2cm)</li>
        </ul>
      </div>
    </div>

    <div class="question">
      <strong>5. What are the principles of treatment of an anal carcinoma?</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <p><strong>Treatment Principles for Anal Carcinoma:</strong></p>

        <h3>Historical Treatment</h3>
        <ul>
          <li>In the past, <strong>abdominoperineal resection and permanent colostomy</strong> were the mainstays of treatment for both types of cancer</li>
        </ul>

        <h3>Current Treatment for Epidermoid Anal Cancer</h3>
        <ul>
          <li><strong>Now almost completely abandoned surgery in favour of combined modality chemotherapy and radiation therapy</strong></li>
          <li><strong>Using protocol of pelvic radiation with infusion of 5-FU and mitomycin C</strong>, sometimes referred to as <strong>Nigro regime</strong> after American surgeon who introduced same in late 1970s</li>
          <li><strong>5-year survival rates now approximately 85%</strong></li>
        </ul>

        <h3>Role of Surgery in Epidermoid Cancer</h3>
        <ul>
          <li><strong>Surgery (abdominoperineal excision of rectum) indicated in cases where residual tumour is present after radiation and chemotherapy</strong></li>
          <li><strong>Recurrence of anal canal cancer after combined modality therapy requires (salvage) abdominoperineal excision of rectum</strong></li>
        </ul>

        <h3>Lymph Node Management</h3>
        <ul>
          <li><strong>Prophylactic inguinal node dissection is not recommended</strong> (unless clinically palpable nodes are present) because of high morbidity associated with this procedure</li>
          <li><strong>Synchronous inguinal node metastasis is an ominous sign and survival rates are poor</strong></li>
          <li><strong>Conversely, metachronous inguinal lymph node involvement has a better prognosis</strong></li>
          <li>Inclusion of the inguinal lymph nodes in radiation field decreases the incidence of metachronous lymph node involvement without adding much morbidity</li>
        </ul>

        <h3>Malignant Melanoma Treatment</h3>
        <ul>
          <li><strong>For malignant melanoma, the prognosis is dismal, regardless of the treatment</strong></li>
          <li>For good-risk patients, abdominoperineal resection is a reasonable option to maximize survival</li>
        </ul>
      </div>
    </div>

    <div class="question">
      <strong>6. In a table briefly outline the clinical presentation of a) anal condylomas, b) anal chlamydial infection, c) anal gonorrhea, and d) anal HSV.</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <p><strong>Clinical Presentation of Common Anorectal Sexually Transmitted Diseases:</strong></p>
        <p>More than 20 sexually transmitted diseases can be present in the anorectal area. Therefore it is important to inquire about a complete sexual history in patients with anorectal symptoms.</p>

        <table>
          <thead>
            <tr>
              <th>Condition</th>
              <th>Clinical Features</th>
              <th>Treatment</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td><strong>Anal Condylomas<br>(HPV)</strong></td>
              <td>
                <ul>
                  <li>Caused by human papilloma virus</li>
                  <li>Most common anorectal infection affecting homosexual men</li>
                  <li>May also be seen in heterosexual men and women - and even children</li>
                  <li>Transmission at birth and by close contact with infected patients has been reported</li>
                  <li><strong>In men:</strong> lesions found perianally, intraanally, on the penis and in the urethra</li>
                  <li><strong>In women:</strong> also in the vulva, vagina, cervix and urethra</li>
                  <li><strong>Condylomata acuminata are pink or white papillary lesions</strong></li>
                  <li>Vary in size from 1mm to large cauliflower-like lesions</li>
                  <li>They bleed easily</li>
                  <li>Difficulty in perianal hygiene may lead to pruritus ani</li>
                  <li>Discomfort and pain often present</li>
                </ul>
              </td>
              <td>
                <ul>
                  <li>Various topical caustic agents (e.g. podophyllin)</li>
                  <li>Local destruction (electrocoagulation, diathermy, liquid nitrogen cryotherapy, laser) techniques</li>
                  <li>High recurrence rates (10% to 50%) with all local treatments</li>
                  <li>Interferon can be used</li>
                  <li>New HPV vaccines promising - now available in Australia</li>
                </ul>
              </td>
            </tr>
            <tr>
              <td><strong>Anal Chlamydial Infection</strong></td>
              <td>
                <ul>
                  <li>Among the most common sexually transmitted disease</li>
                  <li>Chlamydial proctitis increasing in homosexual men</li>
                </ul>
              </td>
              <td>
                <ul>
                  <li>Tetracycline or doxycycline</li>
                  <li>Erythromycin in certain patients</li>
                </ul>
              </td>
            </tr>
            <tr>
              <td><strong>Anal Gonorrhea<br>(Neisseria gonorrhoeae)</strong></td>
              <td>
                <ul>
                  <li>Neisseria gonorrhoeae infections of the rectum account for as many as 50% of the cases of gonorrhoea in homosexual men</li>
                  <li>Most patients have nonspecific complaints, including pruritus, tenesmus, and hematochezia</li>
                  <li><strong>Sigmoidoscopy shows:</strong> thick, yellow mucopurulent discharge; rectal mucosa ranges from normal to erythematous and edematous</li>
                  <li>Culture and gram stain are used for organism identification</li>
                  <li>Evaluation and follow up require cultures of the urethra, rectum and pharynx</li>
                </ul>
              </td>
              <td>
                <ul>
                  <li>Ceftriaxone 250 mg IM single stat dose</li>
                </ul>
              </td>
            </tr>
            <tr>
              <td><strong>Anal HSV<br>(Herpes Simplex Virus Type 2)</strong></td>
              <td>
                <ul>
                  <li>Herpes simplex virus type 2 causes herpetic proctitis</li>
                  <li>Infection acquired by direct inoculation</li>
                  <li>Approximately 15% of homosexual men with rectal symptoms have only this virus identified by rectal culture</li>
                  <li><strong>Symptoms begin 4 to 28 days after inoculation:</strong> majority of patients have pain and burning worsened by bowel movements</li>
                  <li><strong>Some patients have lumbosacral radiculopathy syndrome:</strong> sacral paraesthesia, impotence, lower abdominal/buttock/thigh pain, urinary dysfunction</li>
                  <li><strong>Lesions include:</strong> vesicles with red areolae, ruptured vesicles, and aphthous ulcers</li>
                  <li><strong>Usual locations:</strong> perianal skin, anal canal, and lower rectum</li>
                  <li>Patients who are seen in the relapsing stage may report a history of crusting lesions followed by healing</li>
                  <li>Scrapings for cytologic examination show intranuclear inclusion bodies and giant cells</li>
                </ul>
              </td>
              <td>
                <ul>
                  <li>Treatment aimed at relieving symptoms: sitz baths, topical anaesthetics, and analgesics</li>
                  <li>Acyclovir (famvir) has benefit in the acute and relapse phases</li>
                  <li>Continuous suppressive therapy is warranted only in the most severe cases</li>
                </ul>
              </td>
            </tr>
          </tbody>
        </table>
      </div>
    </div>

  
</div>

<!-- JavaScript -->  <script src="../js/firebase-config.js"></script>
  <script src="../js/dark-mode.js"></script>
  <script src="../js/auth.js"></script>
  <script src="../js/user-analytics.js"></script>
  <script src="../js/analytics-integration.js"></script>
  <script src="../js/completion-tracker.js"></script>
  <script src="../js/flag-tracker.js"></script>
  <script src="../js/case-interactions.js"></script>

  <script>
    // Toggle case completion
    function toggleCaseCompletion() {
      if (window.completionTracker) {
        const caseId = window.completionTracker.getCurrentCaseId();
        if (caseId) {
          window.completionTracker.toggleCompletion(caseId);
        }
      }
    }// Toggle case flag
    function toggleCaseFlag() {
      console.log('toggleCaseFlag() function called');
      console.log('window.flagTracker exists:', !!window.flagTracker);

      if (!window.flagTracker) {
        console.error('window.flagTracker is not defined!');
        alert('Flag tracker not initialized. Please refresh the page.');
        return;
      }

      const caseId = window.flagTracker.getCurrentCaseId();
      console.log('Current case ID:', caseId);

      if (!caseId) {
        console.error('Could not get case ID');
        alert('Could not determine case ID');
        return;
      }

      console.log('Calling window.flagTracker.toggleCaseFlag with caseId:', caseId);
      window.flagTracker.toggleCaseFlag(caseId);
    }

    // Update case flag button state on page load
    document.addEventListener('DOMContentLoaded', () => {
      if (window.flagTracker) {
        setTimeout(() => {
          const caseId = window.flagTracker.getCurrentCaseId();
          if (caseId) {
            window.flagTracker.updateCaseFlagButton(caseId);
          }
        }, 100);
      }
    });
    }
  </script>

</body>
</html>
